Drugs Made in Space: Why Varda Is Worth $1.6 Billion | Tech Arcade Podcast

Oct 7, 2026 · News · Startups & funding

Varda sends small capsules into orbit, grows drug crystals in microgravity, and parachutes them back to Utah. It has just raised about $250 million, at a valuation Reuters reports as $1.6 billion. Here's how it works, why crystal structure matters, and the catch: no medicine made by Varda has reached a patient yet.

Full story: https://www.techarcade.io/varda-grows-drugs-in-orbit-parachutes-them-home-and-just-priced-that-at-1-6-billion/

Sources

Varda press release: https://www.prnewswire.com/news-releases/varda-announces-251-million-series-d-to-scale-space-based-pharmaceutical-processing-302893651.html

Reuters (via WBOW): https://1027wbow.com/2026/09/30/varda-raises-250-million-at-1-6-billion-valuation-to-scale-orbital-drug-manufacturing/

Note: Varda's release gives the round as $251 million; Reuters reported $250 million.

More at https://www.techarcade.io

#techarcade #technews #space #biotech #startups

Watch on YouTube ↗Subscribe

AI

From Code to Cabinets: Lila Sciences Raises the Bar on AI-Powered Science

The startup world lives for big rounds but every once in a while you get one that feels like a signal: Lila Sciences, founded just two years ago, has raised an additional $115 million in an extension of its Series A round, pushing its valuation past $1.3 billion. That’s no small feat. It means inves

· 2 min

▶ More videos

Video library →